FDA layoffs included reviewers working on Musk's Neuralink
The cuts removed specialists reviewing a high-risk brain-implant company owned by the official leading the reduction campaign.
Entities and roles
- NeuralinkMusk company with products under FDA review
- Robert F. Kennedy Jr.Trump-appointed health and human services secretary
- Elon MuskTrump-appointed senior adviser who led DOGE work
- Donald J. Trumppresident authorizing the administration action
- Food and Drug Administrationregulator whose Neuralink reviewers were dismissed
Relationships in this file
- Neuralinkhad implant products under review byFood and Drug Administration
- Donald J. TrumpTrump-appointed health and human services secretaryRobert F. Kennedy Jr.
- Donald J. TrumpTrump-appointed senior adviser who led DOGE workElon Musk
Claims and evidence
- analysisreported
Reuters reported that FDA employees reviewing Neuralink's brain-implant work were among probationary staff dismissed in the DOGE-era purge; the personnel overlap created a direct conflict risk but did not establish that Musk selected individual reviewers for firing.
- Reuters: FDA staff reviewing Musk's Neuralink were included in DOGE employee firingsPassages and source records documenting: FDA layoffs included reviewers working on Musk's Neuralink
- factdocumented
Robert F. Kennedy Jr. was the Trump-appointed health and human services secretary.
- U.S. Department of Health and Human Services: Robert F. Kennedy, Jr.Appointment or biography record identifying Robert F. Kennedy Jr. as Trump-appointed health and human services secretary
- factdocumented
Elon Musk was the Trump-appointed senior adviser who led DOGE work.
- The White House: President Trump participates in a press conference with departing DOGE adviser Elon MuskAppointment or biography record identifying Elon Musk as Trump-appointed senior adviser who led DOGE work